This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Luong, M. Articles by Rabkin, S. Search for Related Content PubMed PubMed Citation Articles by Luong, M. Articles by Rabkin, S. Social Bookmarking                         What's this?

Verapamil but not calpain or creatine alters arsenate-induced cardiac cell death

Department of Medicine (Cardiology), University of British Columbia, Vancouver, British Columbia, Canada

SW Rabkin

Department of Medicine (Cardiology), University of British Columbia, Vancouver, British Columbia, Canada rabkin{at}interchange.ubc.ca

The objective of this study was to examine the potential of arsenate to induce cardiomyocyte cell death and to explore the cellular mechanisms of arsenate toxicity. Isolated cardiomyocytes in culture from embryonic chick hearts were treated with a pentavalent arsenic species (H₃AsO₄) or arsenate. Arsenate produced a significant (P < 0.01) concentration-dependent increase in cell death with an EC₅₀ about 1 mM. Cardiomyocytes manifested a loss of actin structure, reduced size, and damaged nuclei. Creatine 0.1–100 uM did not significantly modify arsenate-induced cell death. In contrast, verapamil, 0.01–1 uM, produced a significant concentration-dependent accentuation of arsenate-induced cell death. The effect of verapamil was evident at low concentrations of arsenate, which produced only a small increase in cell death, and at high concentrations of arsenate, which induced a large amount of cell death. Verapamil alone did not alter cardiomyocyte cell death. By comparison, calpain inhibitor II did not modify arsenate-induced cardiomyocyte cell death. These data suggest that cardiomyocytes are vulnerable to the effects of verapamil to increase the cellular toxicity of arsenate. Two potential cellular mechanisms of arsenate toxicity, however, are likely not involved in arsenate toxicity namely calpain activation and reduction of creatine phosphate production.

Key Words: arsenate • calpain • cell death • creatine • heart • verapamil

Toxicology and Industrial Health, Vol. 25, No. 3, 169-176 (2009)
DOI: 10.1177/0748233709105593


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?